Summary Pelago Bioscience AB (Pelago Bioscience) provides and develops the patented cellular thermal shift assay for use in determination and quantification of drug–target interactions. It utilizes patented CETSA technology which enables direct, in situ physiologically relevant measurements of target engagement on target proteins in lysate, intact cells and tissue samples. Pelago Bioscience delivers in situ target engagement studies to accelerate the preclinical and clinical drug discovery and diagnostics development. It also works in partnership with other organizations which enables them to utilize the CETSA technology. The organization is a spun out from the Karolinska Institute, Stockholm, Sweden. Pelago Bioscience is headquartered in Solna, Sweden. Pelago Bioscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and... Research Beam Model: Research Beam Product ID: 2637847 250 USD New
Pelago Bioscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Pelago Bioscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : October   2017
  • Pages : 19
  • Publisher : GlobalData
 
 
 
Summary

Pelago Bioscience AB (Pelago Bioscience) provides and develops the patented cellular thermal shift assay for use in determination and quantification of drug–target interactions. It utilizes patented CETSA technology which enables direct, in situ physiologically relevant measurements of target engagement on target proteins in lysate, intact cells and tissue samples. Pelago Bioscience delivers in situ target engagement studies to accelerate the preclinical and clinical drug discovery and diagnostics development. It also works in partnership with other organizations which enables them to utilize the CETSA technology. The organization is a spun out from the Karolinska Institute, Stockholm, Sweden. Pelago Bioscience is headquartered in Solna, Sweden.

Pelago Bioscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pelago Bioscience AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pelago Bioscience AB, Medical Devices Deals, 2011 to YTD 2017 9
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
WuXi AppTec to Partner with Pelago Bioscience 11
Biovica Enters into Agreement with Pelago Bioscience 12
Licensing Agreements 13
Pelago Bioscience Enters into Licensing Agreement with OmicScouts 13
GlaxoSmithKline Enters into Licensing Agreement with Pelago Bioscience for CETSA 14
Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 15
Pelago Bioscience AB - Key Competitors 16
Pelago Bioscience AB - Key Employees 17
Pelago Bioscience AB - Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Key Facts 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pelago Bioscience AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pelago Bioscience AB, Deals By Therapy Area, 2011 to YTD 2017 8
Pelago Bioscience AB, Medical Devices Deals, 2011 to YTD 2017 9
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
WuXi AppTec to Partner with Pelago Bioscience 11
Biovica Enters into Agreement with Pelago Bioscience 12
Pelago Bioscience Enters into Licensing Agreement with OmicScouts 13
GlaxoSmithKline Enters into Licensing Agreement with Pelago Bioscience for CETSA 14
Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 15
Pelago Bioscience AB, Key Competitors 16
Pelago Bioscience AB, Key Employees 17
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter